Press Release

IP Infusion Supports Edgecore Networks' Whitebox "Cassini" Packet Transponder contributed to the Telecom Infra Project

SANTA CLARA, Calif., November 8, 2017 – IP Infusion, a leader in disaggregated networking solutions, announced today that it supports the hardware design of the "Cassini" packet transponder, developed by Edgecore Networks®, the leader in open networking, with other industry partners. Cassini offers a whitebox solution for data center interconnect and service provider use cases, which supports the OcNOS™ disaggregated switching software from IP Infusion.

Edgecore Networks contributed to the hardware design for the Cassini packet transponder for the Open Optical Packet Transport project group in Telecom Infra Project (TIP).  Cassini is the industry's highest capacity and first modular whitebox packet transponder to offer a flexible mix of 100 Gigabit Ethernet (GbE) packet switching ports and 100/200 Gbps coherent optical interfaces for metro and long-haul connections.

"With the explosion in data center traffic, enterprises need to interconnect geographically dispersed locations to scale applications and take care of high availability and redundancy demands," said Atsushi Ogata, President and CEO of IP Infusion.  "By offering our OcNOS network operating system on Edgecore's Cassini packet transponder, our data center and service provider customers can integrate packet switching and optical transport technology and handle increased demands on their open network, disaggregated networks."

The OcNOS network operating system, combined with the Edgecore platform, extends virtualized services between sites; increases total capacity both inside and between locations; and enhances network resilience. With the ability to adopt cloud-scale economic solutions, enterprises can easily extend and migrate existing metro and long-haul Dense Wavelength Division Multiplexing (DWDM) networks to add new 100G capacities, and extend inter-DC L2 and L3 services.

The Cassini packet transponder is a 1.5RU form factor with system throughput of 3.2Tbps based on Broadcom StrataXGS™ Tomahawk™ Plus switch silicon.  The Cassini design offers 16 fixed 100 Gigabit Ethernet QSFP28 ports, plus eight line card slots to incorporate a flexible mix of additional 100GbE ports or ACO/DCO optical ports based on coherent DSP and optical transceivers from leading optical technology partners.

For more information on OcNOS, please see https://www.ipinfusion.com/products/ocnos.

关于 IP Infusion

 

IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.

 

IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.

 

IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.

 

-end-

 

媒体联系

 

Katherine Verducci, 1903 PR, kverducci@1903pr.com, 408.429.5779

关于 IP Infusion

IP Infusion 是开放网络软件的领先供应商,提供面向服务提供商、数据中心和 AI Fabric 网络的运营商级网络操作系统 OcNOS。凭借自 1999 年以来的网络技术积累和全球 600+ 家运营商的部署,IP Infusion 在 Edgecore Networks、UfiSpace 和 Celestica 等合作伙伴经过验证的开放硬件上,实现开放、多厂商、高性价比且灵活的网络基础设施。IP Infusion 是 ACCESS CO., LTD.(东京证券交易所:4813)的全资子公司。

媒体联系

For press inquiries, analyst briefings, or media materials, please 联系我们团队 or email pr@ipinfusion.com.

前瞻性陈述

本新闻稿可能包含有关 IP Infusion 产品、技术和计划的前瞻性陈述。前瞻性陈述基于发布之日可获得的信息,涉及风险和不确定性,实际结果可能存在差异。产品计划、功能、发布时间和供应情况可能随时变更,恕不另行通知,且不构成任何承诺、保证或法律义务。IP Infusion 不承担更新任何前瞻性陈述的义务。